We have exciting news!

Alpine Vision is pleased to offer Macula Risk PGx testing for our Age-Related Macular Degeneration (ARMD) patients. This DNA test provides prognostic and pharmacogenetic information for patients who suffer from early or intermediate stages of the disease. A cheek swab is conducted in office

and the results are available within weeks. The test assesses risk for progression to advanced forms of ARMD within 2, 5, and 10 years and provides a genetic profile of the specific genes carried. Additionally, the results include information about the appropriate eye vitamin therapy recommended for maximum preservation of the patient’s vision. As new treatment options become available, the information provided by this test may allow doctors to tailor treatments based on the patient’s genetic profile.

If you are interested in learning more about Macula Risk please schedule an appointment with one of our providers or visit the website, http://www.macularisk.com.